RHS Advisors LLC
Call: 732-616-9744
1
Home
About
Services
Contact
News & Information
Long & Short
Insights on Biotech Investment
Additional information on biotech investing is available in the following articles:
Red Flags for Biotech Investors - Part I
Press Releases, Reading Between the Lines - Part II
Vical: Buy, Sell or Short
The Importance of Third Party Validation - Part III
December 28, 2012 -New Link Genetics' Hyperacute(R) Pancreatic Cancer Vaccine Likely to Disappoint Investors in 2013
January 10, 2013 - Is_Teva_s_Petition_For_A_Protracted_Review_Of_Biogen_Idec's_BG-12_Cause_For_An_Antitrust_Challenge
January 21, 2013 - OPINION: CELSION, SELL OR SHORT
February 12, 2013 - Galena Biopharma's (GALE) NeuVax(TM) Vaccine: What to Know Before You Invest
February 25, 2013 - Peregrine Pharmaceuticals' Bavituximab: It's Time to Throw in the Towel
robert@rhsadvisors.com
March 14, 2013 - Ziopharm Oncology May Win The Battle But Will They Win The War?
March 20, 2013 - Why AVEO Pharmaceuticals' Tivozanib Will Be Approved For The Treatment Of Advanced Renal Cell Carcinoma
